发明授权
- 专利标题: High molecular weight polylactic acid synthesized via polycondensation catalyzed by bionic creatinine guanidinium chloride
- 专利标题(中): 通过由仿生肌酐氯化胍催化的缩聚合成的高分子量聚乳酸
-
申请号: US14129323申请日: 2011-11-02
-
公开(公告)号: US09062006B2公开(公告)日: 2015-06-23
- 发明人: Hong Li , Quanxing Zhang , Wei Huang , Wei Jiang , Xupeng Zong , Bingcai Pan
- 申请人: Hong Li , Quanxing Zhang , Wei Huang , Wei Jiang , Xupeng Zong , Bingcai Pan
- 申请人地址: CN Nanjing
- 专利权人: NANJING UNIVERSITY
- 当前专利权人: NANJING UNIVERSITY
- 当前专利权人地址: CN Nanjing
- 代理机构: Rankin, Hill & Clark LLP
- 优先权: CN201110181170 20110630
- 国际申请: PCT/CN2011/081700 WO 20111102
- 国际公布: WO2013/000226 WO 20130103
- 主分类号: C08G63/87
- IPC分类号: C08G63/87 ; C07D233/50 ; A61L27/18 ; A61L31/06 ; A61K47/34 ; A61L17/12 ; C07D233/32 ; C08G63/06
摘要:
Disclosed is a high molecular weight polylactic acid synthesized by using a method for synthesizing and catalytically-polycondensing bionic creatinine-guanidinium chloride. Creatinine is used as the material in a reaction with aqueous hydrochloric acid to synthesize a bionic creatinine-guanidinium salt catalyst, creatinine-guanidinium chloride (CR.Cl). The creatinine-guanidinium chloride synthesized is used as a catalyst, an industrial grade lactic acid (LA, 85% to 90%, aqueous solution) is used as a monomer, a solvent-free two-step polycondensation method is used to synthesize and afford metal-free and toxic residue-free polylactic acid featuring high biological safety and high molecular weight.
公开/授权文献
信息查询